William Carson is a distinguished pharmaceutical and biotechnology leader with a strong background in global regulatory interactions, M&A strategy, joint ventures, and process governance.

As of January 1, 2020, he holds the position of Chairman of the Board at Otsuka Pharmaceutical Development & Commercialization, Inc. where he previously served as President & CEO. He is also responsible for leading Otsuka philanthropic initiatives.

Dr. Carson is recognized for developing drugs and digital medicines approved by global regulatory authorities, creating significant value while positively impacting patients' lives and society overall.

He is a Board-certified psychiatrist and a Distinguished Fellow of the American Psychiatric Association, holding an A.B. from Harvard College and an M.D. from Case Western Reserve University.

Apart from his role at Otsuka, he serves on various boards including Excision Biotherapeutics, Inc. and Internet2, contributing his expertise in advancing gene-editing therapeutics and supporting technological innovation for research and education organizations.

Additionally, Dr. Carson is a co-founder of ExtendATouch, a virtual community of caregivers focused on leveraging technology to empower millions of caregivers around the world.

His core competencies encompass global regulatory processes, stakeholder engagement, problem-solving, M&A activities, new product approvals, commercialization strategies, strategic partnerships, cross-functional collaboration, business analysis, and budget oversight.

Through his extensive professional journey and leadership roles in organizations like Saama, Annexon Biosciences, and Bexson Biomedical, Dr. Carson has demonstrated a strong commitment to driving innovation and transformative changes within the pharmaceutical and biotechnology sectors.